NantHealth (NASDAQ:NH) Downgraded by Zacks Investment Research to Sell

0
20
Businessman with statistic graph of stock market financial indices analysis on laptop screen, finance data and technology concept

NantHealth stock has undergone multiple analysts rating changes in the recent past.  NantHealth Downgraded by Zacks Investment Research on 6/30/2020. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

Shares of NantHealth traded down -$0.18 on Monday, reaching $4.12. 26 shares of the stock traded hands, compared to its average volume of 924798. Shares of NantHealth ended Monday on at $4.12. The firm’s 50 day moving average is $2.85 and its 200 day moving average is $1.64.NantHealth  has a 12 month low of $3.68 and a 12 month high of $5.37. While on yearly highs and lows, NantHealth’s today has traded high as $4.24 and has touched $3.68 on the downward trend. See More Analyst Rating at: RATING

NantHealth Earnings and What to expect: 

NantHealth last announced its earnings data on May 7th, 2020. The reported ($0.06) EPS for the quarter, meeting analysts’ consensus estimates of ($0.06). The business had revenue of $18.18 million for the quarter, compared to the consensus estimate of $19.30 million. NantHealth has generated ($0.57) earnings per share over the last year. NantHealth has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 13th, 2020 based off prior year’s report dates.

Earnings for NantHealth are expected to grow in the coming year, from ($0.34) to ($0.31) per share. The P/E ratio of NantHealth is -22.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of NantHealth is -22.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 59.60%
  • On 10/6/2018 Insider Ronald Allen Louks Sell 6,304 at average share price of $1.42 which equates to $8,951.68 in money value.
  • On 9/6/2018 Insider Ronald Allen Louks Sell 6,305 at average price of  $1.89 with total value of : Not Data Available
  • On 8/6/2018 COO Ronald Allen Louks Sell 6,304 at average price of  $3.15 with total value of : $19,857.60

Analyst at Zacks Investment Research are also talking about :

  • 6/24/2020 – NantHealth was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating.
  • 6/24/2020 – NantHealth was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 5/12/2020 – NantHealth was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 4/2/2020 – NantHealth was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.

NantHealth (NASDAQ:NH) Moving Average Technical Analysis

5 day Moving Average is $4.38 And 5 day price change is $0.52 (14.44%)  with average volume for 5 day average is 2,165,640. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $3.45 and 20 day price change is $1.23 (42.56%) and average 20 day moving volume is 1,288,405. 50 day moving average is $2.85  and 50 day price change is $2.09 ( 102.96%)  and with average volume for 50 days is : 678,838. 200 day moving average is $1.64  and 200 day price change is $3.31 (409.90%)  and with average volume for 200 days is : 476,242.

See More Analyst Rating at: RATING